Abbott Acquisition of Alere Cleared by European Commission

Jan 25, 2017

|

NEW YORK (GenomeWeb) – Alere said today that the European Commission has granted clearance for its acquisition by Abbott.

The announcement came almost immediately after Abbott completed its fourth quarter earnings call, which was notable in part for its relative silence about the proposed Alere acquisition.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Abbott Acquisition of Alere Cleared by European Commission

To read the full story....

Breaking News

Exact Sciences, Express Gene, Avera Institute Get FDA EUAs for Coronavirus Tests

AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests

P23 Labs Receives FDA Emergency Use Authorization for SARS-CoV-2 Test

Genedrive Receives CE Mark for SARS-CoV-2 PCR Kit

Local Coverage Determinations Roundup: Aspira Labs, Fujirebio Diagnostics

Featured White Papers

COVID-19 Testing, Treatment and Future Outlook

What's Popular?

Head-to-Head Comparisons of Commercial SARS-CoV-2 MDx Tests Point to Few Differences in Accuracy

CMS Sets Reimbursement Rates for SARS-CoV-2 Serology Tests

BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests

Genedrive Receives CE Mark for SARS-CoV-2 PCR Kit

BioMérieux's BioFire Pneumonia Panel Could Improve Care, Find Secondary Infection in COVID-19 Cases

Sponsorships